Business Context and Reporting Period
This Form 6-K filing by SciSparc Ltd. covers the month of May 2023, with the report dated May 5, 2023. The filing discloses a material legal proceeding initiated against the Company by Capital Point Ltd. in the Tel Aviv-Jaffa District Court.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific legal contingency rather than general financial performance.
Material Changes and Legal Proceedings
On May 2, 2023, Capital Point Ltd. filed a lawsuit (Case No. 2050-05-23) against SciSparc Ltd. The suit alleges breaches of contract, unjust enrichment, and torts related to a warrant issued to Capital Point in connection with a 2020 joint venture.
- Dispute Subject: The Company allegedly refused to accept an exercise notice for the "Capital Point Warrant" on November 4, 2021, and failed to issue the corresponding shares.
- Warrant Details: The warrant allowed the purchase of 340,000 ordinary shares and was exercisable between May 15, 2021, and May 15, 2022.
- Claims: Capital Point seeks damages of NIS 10,000,000 (approximately $2.75 million), an injunction to force the issuance of the shares, return of unlawful profits, and punitive damages.
Outlook, Risks, and Management Commentary
Management states that as of the filing date, the Company cannot predict the likelihood of success regarding the lawsuit. The filing notes that this report is incorporated by reference into several existing registration statements on Forms F-3 and S-8.
Investor Verification Checklist
- Verify the current status of the lawsuit (Case No. 2050-05-23) and any subsequent court rulings.
- Confirm the potential financial impact of the NIS 10,000,000 claim relative to the Company's total assets and cash position.
- Review the original 2020 joint venture agreement and the specific terms of the Capital Point Warrant to assess the validity of the breach allegations.
- Monitor for any updates on the Company's ability to issue the 340,000 disputed shares if an injunction is granted.